Altogether, these results indicate that TEM1 and MMP-2 were co-expressed in uterine leiomyosarcoma tissues, especially high-grade lesions, suggesting poor prognosis in uterine leiomyosarcoma patients. This evidence concerns the gene MMP2 and leiomyosarcoma.